Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 16/20 | 0.68 |
| ▸ | CCND1 | P24385 | 15/20 | 0.68 |
| ▸ | CDK2 | P24941 | 13/20 | 0.68 |
| ▸ | CCNE2 | O96020 | 12/20 | 0.68 |
| ▸ | CCNE1 | P24864 | 12/20 | 0.68 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.54 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | ALPL | P05186 | 1/20 | 0.44 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.43 |
| ▸ | CDK1 | P06493 | 1/20 | 0.43 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.43 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7090159 | 0.87 | CDK4 (0.71) | CDK4CCND1CDK2CCNE2CCNE1 | |
| SCHEMBL4816704 | 0.85 | CDK4 (0.68) | CDK4CCND1CDK2CCNE2CCNE1 | |
| SCHEMBL7145484 | 0.85 | CDK4 (0.68) | CDK4CCND1CDK2CCNE2CCNE1 | |
| SCHEMBL7148608 | 0.83 | CDK4 (0.66) | CDK4CCND1CDK2CCNE2CCNE1 | |
| SCHEMBL8423884 | 0.78 | ALDH1A1 (0.51) | CDK4CCND1CDK2CCNE2CCNE1 | |
| SCHEMBL7091188 | 0.77 | CCNE2 (0.69) | CDK4CCND1CDK2CCNE2CCNE1 | |
| SCHEMBL7140772 | 0.75 | CDK4 (0.70) | CDK4CCND1CDK2CCNE2CCNE1 | |
| SCHEMBL12856433 | 0.74 | CDK2 (0.55) | CDK4CCND1CDK2CCNE2CCNE1 | |
| SCHEMBL7093050 | 0.74 | CCNE1 (0.55) | CDK4CCND1CDK2CCNE2CCNE1 | |
| SCHEMBL20035506 | 0.73 | ALDH1A1 (0.53) | CDK4CCND1CDK2CCNE2CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6534655-B1 | Administering as anti-angiogenic compounds or to inhibit vascular hyperpermeability | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-18 | — | — | US | disclosed |
| EP-1021182-A1 | INDENO[1,2-C] PYRAZOLE DERIVATIVES FOR INHIBITING TYROSINE KINASE ACTIVITY | BASF AKTIENGESELLSCHAFT (DE) | 2000-07-26 | — | — | EP | disclosed |
| WO-1999017770-A1 | INDENO[1,2-C]PYRAZOLE DERIVATIVES FOR INHIBITING TYROSINE KINASE ACTIVITY | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-15 | — | — | WO | disclosed |